Employees Area
Functional Compliance Program

Pharmacovigilance:

To meet the local and international Pharmacovigilance and safety requirements, Martin Dow has clearly defined and implemented a procedure to guide all employees, on how to collect information and report, whenever they receive or collect information related to:

 

  • Spontaneous Adverse Drug Reactions (ADRs) and Adverse Events (AEs) / Serious Adverse Events (SAEs)
  • ADRs and AEs related to any clinical trial and observational study
  • Usage and outcome in pregnancy, if approved for a product
  • Customer technical complaints of all types
  • Any other safety information.

Corporate Compliance:

In accordance with our corporate vision, mission and values, Martin Dow has developed the Functional Compliance Program. Executing our business within the boundaries of this program will ensure the successes we realize are accomplished honestly, fairly and with the utmost respect for healthcare professionals, patients and employees.

 

The Functional Compliance Program contains the fundamental legal, regulatory and ethical guidelines of relevant local applicable laws and requirements of contractual associations or business associates, for conducting business at Martin Dow. It summarizes our compliance infrastructure and policies and serves as a valuable source for compliance questions and concerns.

Facebook

News & Media

  • Martin Dow announces the National Consensus Guidelines for Chemoprophylaxis & Surgical Site Infections
    Martin Dow announces the National Consensus Guidelines for Chemoprophylaxis & Surgical Site Infections
    (August 3, 2017)

    Read More
  • Martin Dow in talks to buy French biotech firm
    Martin Dow in talks to buy French biotech firm
    (April 12, 2017)

    Read More
  • Martin Dow Pharmaceuticals Inauguration : Meymac France
    Martin Dow Pharmaceuticals Inauguration : Meymac France
    (March 24, 2017)

    Read More
  • World Osteoporosis Day Radio Program
    World Osteoporosis Day Radio Program
    (February 6, 2017)

    Read More
  • Martin Dow-Biocodex to supply Enflor
    Martin Dow-Biocodex to supply Enflor
    (January 18, 2017)

    Read More
  • TerraBiz to hold first M&A moot on December 7
    TerraBiz to hold first M&A moot on December 7
    (January 18, 2017)

    Read More
  • French President to inaugurate Pakistani Pharma Plant in France
    French President to inaugurate Pakistani Pharma Plant in France
    (January 18, 2017)

    Read More
  • Martin Dow acquires Merck operations in Pakistan
    Martin Dow acquires Merck operations in Pakistan
    (January 18, 2017)

    Read More
  • World Mental Health Day
    World Mental Health Day
    (December 22, 2016)

    Read More
  • France Trade & Investment Report 2016
    France Trade & Investment Report 2016
    (July 14, 2016)

    Read More
  • Serving the changing world
    Serving the changing world
    (November 16, 2015)

    Read More
  • Martin Dow setting up clinic for IBA students
    Martin Dow setting up clinic for IBA students
    (November 14, 2015)

    Read More
  • Awarding Dr. Ishrat Hussain
    Awarding Dr. Ishrat Hussain
    (August 31, 2015)

    Read More
  • Martin Dow and quality healthcare go together
    Martin Dow and quality healthcare go together
    (July 14, 2015)

    Read More
  • Martin Dow donates Rs 1 million to IBA
    Martin Dow donates Rs 1 million to IBA
    (April 4, 2015)

    Read More
  • MD Biocodex sign deal
    MD Biocodex sign deal
    (February 26, 2015)

    Read More